<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37296571</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>23</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Astrocytes: Dissecting Their Diverse Roles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1450</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12111450</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are fatal neurodegenerative disorders often co-occurring in the same patient, a feature that suggests a common origin of the two diseases. Consistently, pathological inclusions of the same proteins as well as mutations in the same genes can be identified in both ALS/FTD. Although many studies have described several disrupted pathways within neurons, glial cells are also regarded as crucial pathogenetic contributors in ALS/FTD. Here, we focus our attention on astrocytes, a heterogenous population of glial cells that perform several functions for optimal central nervous system homeostasis. Firstly, we discuss how post-mortem material from ALS/FTD patients supports astrocyte dysfunction around three pillars: neuroinflammation, abnormal protein aggregation, and atrophy/degeneration. Furthermore, we summarize current attempts at monitoring astrocyte functions in living patients using either novel imaging strategies or soluble biomarkers. We then address how astrocyte pathology is recapitulated in animal and cellular models of ALS/FTD and how we used these models both to understand the molecular mechanisms driving glial dysfunction and as platforms for pre-clinical testing of therapeutics. Finally, we present the current clinical trials for ALS/FTD, restricting our discussion to treatments that modulate astrocyte functions, directly or indirectly.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valori</LastName><ForeName>Chiara F</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0001-5993-6522</Identifier><AffiliationInfo><Affiliation>Molecular Neuropathology of Neurodegenerative Diseases, German Centre for Neurodegenerative Diseases (DZNE), 72072 T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropathology, University of T&#xfc;bingen, 72076 T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sulmona</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory for Research on Neurodegenerative Disorders, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brambilla</LastName><ForeName>Liliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory for Research on Neurodegenerative Disorders, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3346-1327</Identifier><AffiliationInfo><Affiliation>Laboratory for Research on Neurodegenerative Disorders, Istituti Clinici Scientifici Maugeri IRCCS, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="Y">Astrocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">animal models</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">cell models</Keyword><Keyword MajorTopicYN="N">personalized medicine</Keyword><Keyword MajorTopicYN="N">rehabilitation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37296571</ArticleId><ArticleId IdType="pmc">PMC10252425</ArticleId><ArticleId IdType="doi">10.3390/cells12111450</ArticleId><ArticleId IdType="pii">cells12111450</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feldman E.L., Goutman S.A., Petri S., Mazzini L., Savelieff M.G., Shaw P.J., Sobue G. Amyotrophic lateral sclerosis. Lancet. 2022;400:1363&#x2013;1380. doi: 10.1016/S0140-6736(22)01272-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01272-7</ArticleId><ArticleId IdType="pmc">PMC10089700</ArticleId><ArticleId IdType="pubmed">36116464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirola L., Mukherjee A., Mutsuddi M. Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Mol. Neurobiol. 2022;59:5673&#x2013;5694. doi: 10.1007/s12035-022-02934-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02934-z</ArticleId><ArticleId IdType="pubmed">35768750</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahsen B.F., Gray E., Thompson A.G., Ansorge O., Anthony D.C., Cowley S.A., Talbot K., Turner M.R. Non-neuronal cells in amyotrophic lateral sclerosis&#x2014;From pathogenesis to biomarkers. Nat. Rev. Neurol. 2021;17:333&#x2013;348. doi: 10.1038/s41582-021-00487-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-021-00487-8</ArticleId><ArticleId IdType="pubmed">33927394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M., Keyhanian K., Douthwright C. Glial Cell Dysfunction in C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Cells. 2021;10:249. doi: 10.3390/cells10020249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020249</ArticleId><ArticleId IdType="pmc">PMC7912327</ArticleId><ArticleId IdType="pubmed">33525344</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam O.H., Rozhkov N.V., Shaw R., Kim D., Hubbard I., Fennessey S., Propp N., Consortium N.A., Fagegaltier D., Harris B.T., et al. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep. 2019;29:1164&#x2013;1177.e1165. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshima J., O&#x2019;Connor S.A., Marschall E., Consortium N.A., Bowser R., Plaisier C.L., Smith B.S. Molecular subtypes of ALS are associated with differences in patient prognosis. Nat. Commun. 2023;14:95. doi: 10.1038/s41467-022-35494-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35494-w</ArticleId><ArticleId IdType="pmc">PMC9822908</ArticleId><ArticleId IdType="pubmed">36609402</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Zorec R., Parpura V. Stratification of astrocytes in healthy and diseased brain. Brain Pathol. 2017;27:629&#x2013;644. doi: 10.1111/bpa.12537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12537</ArticleId><ArticleId IdType="pmc">PMC5599174</ArticleId><ArticleId IdType="pubmed">28805002</ArticleId></ArticleIdList></Reference><Reference><Citation>Khakh B.S., Deneen B. The Emerging Nature of Astrocyte Diversity. Annu. Rev. Neurosci. 2019;42:187&#x2013;207. doi: 10.1146/annurev-neuro-070918-050443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-070918-050443</ArticleId><ArticleId IdType="pubmed">31283899</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo F., Kasai A., Soto J.S., Yu X., Qu Z., Hashimoto H., Gradinaru V., Kawaguchi R., Khakh B.S. Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science. 2022;378:eadc9020. doi: 10.1126/science.adc9020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adc9020</ArticleId><ArticleId IdType="pmc">PMC9873482</ArticleId><ArticleId IdType="pubmed">36378959</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D. Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death. Prog. Neurobiol. 2015;130:86&#x2013;120. doi: 10.1016/j.pneurobio.2015.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2015.04.003</ArticleId><ArticleId IdType="pubmed">25930681</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Parpura V., Vardjan N., Zorec R. Physiology of Astroglia. Adv. Exp. Med. Biol. 2019;1175:45&#x2013;91. doi: 10.1007/978-981-13-9913-8_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-9913-8_3</ArticleId><ArticleId IdType="pmc">PMC7265998</ArticleId><ArticleId IdType="pubmed">31583584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Sloan S.A., Clarke L.E., Caneda C., Plaza C.A., Blumenthal P.D., Vogel H., Steinberg G.K., Edwards M.S., Li G., et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron. 2016;89:37&#x2013;53. doi: 10.1016/j.neuron.2015.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.013</ArticleId><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Pan L., Pembroke W.G., Rexach J.E., Godoy M.I., Condro M.C., Alvarado A.G., Harteni M., Chen Y.-W., Stiles L., et al. Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes. Nat. Commun. 2021;12:3958. doi: 10.1038/s41467-021-24232-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24232-3</ArticleId><ArticleId IdType="pmc">PMC8233314</ArticleId><ArticleId IdType="pubmed">34172753</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin H., Clarke B.E., Patani R. Astrocytes and microglia in neurodegenerative diseases: Lessons from human in vitro models. Prog. Neurobiol. 2021;200:101973. doi: 10.1016/j.pneurobio.2020.101973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2020.101973</ArticleId><ArticleId IdType="pmc">PMC8052192</ArticleId><ArticleId IdType="pubmed">33309801</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Nagai J., Marti-Solano M., Soto J.S., Coppola G., Babu M.M., Khakh B.S. Context-Specific Striatal Astrocyte Molecular Responses Are Phenotypically Exploitable. Neuron. 2020;108:1146&#x2013;1162.e1110. doi: 10.1016/j.neuron.2020.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.09.021</ArticleId><ArticleId IdType="pmc">PMC7813554</ArticleId><ArticleId IdType="pubmed">33086039</ArticleId></ArticleIdList></Reference><Reference><Citation>Burda J.E., O&#x2019;Shea T.M., Ao Y., Suresh K.B., Wang S., Bernstein A.M., Chandra A., Deverasetty S., Kawaguchi R., Kim J.H., et al. Divergent transcriptional regulation of astrocyte reactivity across disorders. Nature. 2022;606:557&#x2013;564. doi: 10.1038/s41586-022-04739-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04739-5</ArticleId><ArticleId IdType="pmc">PMC10027402</ArticleId><ArticleId IdType="pubmed">35614216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian J.L., Xu L., Foo L.C., Nouri N., Zhou L., Giffard R.G., Barres B.A. Genomic analysis of reactive astrogliosis. J. Neurosci. 2012;32:6391&#x2013;6410. doi: 10.1523/JNEUROSCI.6221-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6221-11.2012</ArticleId><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., Munch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C., Galea E., Lakatos A., O&#x2019;Callaghan J.P., Petzold G.C., Serrano-Pozo A., Steinhauser C., Volterra A., Carmignoto G., Agarwal A., et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 2021;24:312&#x2013;325. doi: 10.1038/s41593-020-00783-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00783-4</ArticleId><ArticleId IdType="pmc">PMC8007081</ArticleId><ArticleId IdType="pubmed">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori C.F., Guidotti G., Brambilla L., Rossi D. Astrocytes in Motor Neuron Diseases. Adv. Exp. Med. Biol. 2019;1175:227&#x2013;272. doi: 10.1007/978-981-13-9913-8_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-9913-8_10</ArticleId><ArticleId IdType="pubmed">31583591</ArticleId></ArticleIdList></Reference><Reference><Citation>Black S.E. Focal Cortical Atrophy Syndromes. Brain Cogn. 1996;31:188&#x2013;229. doi: 10.1006/brcg.1996.0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/brcg.1996.0042</ArticleId><ArticleId IdType="pubmed">8811996</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer D., Cordera S., Cavalla P., Migheli A. Reactive astrogliosis of the spinal cord in amyotrophic lateral sclerosis. J. Neurol. Sci. 1996;139:27&#x2013;33. doi: 10.1016/0022-510X(96)00073-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(96)00073-1</ArticleId><ArticleId IdType="pubmed">8899654</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly S.A., Roedica J., Nagy D., Hallewell R.A., Alderson K., Marklund S.L., Kuby J., Kushner P.D. Motor neuron-astrocyte interactions and levels of Cu,Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 1995;131:203&#x2013;210. doi: 10.1016/0014-4886(95)90042-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4886(95)90042-X</ArticleId><ArticleId IdType="pubmed">7895821</ArticleId></ArticleIdList></Reference><Reference><Citation>Manberg A., Skene N., Sanders F., Trusohamn M., Remnestal J., Szczepinska A., Aksoylu I.S., Lonnerberg P., Ebarasi L., Wouters S., et al. Altered perivascular fibroblast activity precedes ALS disease onset. Nat. Med. 2021;27:640&#x2013;646. doi: 10.1038/s41591-021-01295-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01295-9</ArticleId><ArticleId IdType="pmc">PMC7613336</ArticleId><ArticleId IdType="pubmed">33859435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Saito M., Hirano A., Ohama E. Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: Neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions. Histol. Histopathol. 1999;14:973&#x2013;989. doi: 10.14670/HH-14.973.</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/HH-14.973</ArticleId><ArticleId IdType="pubmed">10425565</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/S0896-6273(00)80272-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80272-X</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana F., Brambilla L., Valori C.F., Bergamaschi C., Roncoroni C., Aronica E., Volterra A., Bezzi P., Rossi D. The BH4 domain of Bcl-X(L) rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals. Hum. Mol. Genet. 2012;21:826&#x2013;840. doi: 10.1093/hmg/ddr513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr513</ArticleId><ArticleId IdType="pubmed">22072391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendonca D.M., Chimelli L., Martinez A.M. Expression of ubiquitin and proteasome in motorneurons and astrocytes of spinal cords from patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2006;404:315&#x2013;319. doi: 10.1016/j.neulet.2006.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2006.06.009</ArticleId><ArticleId IdType="pubmed">16806703</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Houseweart M.K., Brown R.H., Jr., Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2000;97:13901&#x2013;13906. doi: 10.1073/pnas.240305897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.240305897</ArticleId><ArticleId IdType="pmc">PMC17673</ArticleId><ArticleId IdType="pubmed">11095709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y., Tan C.F., Onodera O., Toyoshima Y., Yamada M., Morita T., Nishizawa M., Kakita A., Takahashi H. Sporadic amyotrophic lateral sclerosis: Two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169&#x2013;182. doi: 10.1007/s00401-008-0385-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId><ArticleId IdType="pubmed">18481073</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid M.J., Beltran-Lobo P., Johnson L., Perez-Nievas B.G., Noble W. Astrocytes in Tauopathies. Front. Neurol. 2020;11:572850. doi: 10.3389/fneur.2020.572850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.572850</ArticleId><ArticleId IdType="pmc">PMC7542303</ArticleId><ArticleId IdType="pubmed">33071951</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi E., Aldecoa I., Lopez-Villegas D., Abellan-Vidal M.T., Mercadel-Fananas P., Fortea J., Ribosa R., Morenas E., Gomez-Anson B., Molina-Porcel L., et al. Atypical astroglial pTDP-43 pathology in astroglial predominant tauopathy. Neuropathol. Appl. Neurobiol. 2021;47:1109&#x2013;1113. doi: 10.1111/nan.12707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12707</ArticleId><ArticleId IdType="pmc">PMC9292602</ArticleId><ArticleId IdType="pubmed">33730418</ArticleId></ArticleIdList></Reference><Reference><Citation>Llibre-Guerra J.J., Lee S.E., Suemoto C.K., Ehrenberg A.J., Kovacs G.G., Karydas A., Staffaroni A., Franca Resende E.D.P., Kim E.-J., Hwang J.-H., et al. A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP. Brain Pathol. 2021;31:267&#x2013;282. doi: 10.1111/bpa.12924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12924</ArticleId><ArticleId IdType="pmc">PMC7946775</ArticleId><ArticleId IdType="pubmed">33314436</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng T., Lacrampe A., Hu F. Physiological and pathological functions of TMEM106B: A gene associated with brain aging and multiple brain disorders. Acta Neuropathol. 2021;141:327&#x2013;339. doi: 10.1007/s00401-020-02246-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02246-3</ArticleId><ArticleId IdType="pmc">PMC8049516</ArticleId><ArticleId IdType="pubmed">33386471</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J.H., Nichol K.E., Sitch T., Sheu P., Chubb C., Miller B.L., Tomaselli K.J., Kim R.C., Cotman C.W. DNA damage and activated caspase-3 expression in neurons and astrocytes: Evidence for apoptosis in frontotemporal dementia. Exp. Neurol. 2000;163:9&#x2013;19. doi: 10.1006/exnr.2000.7340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2000.7340</ArticleId><ArticleId IdType="pubmed">10785439</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinac J.A., Craft D.K., Su J.H., Kim R.C., Cotman C.W. Astrocytes degenerate in frontotemporal dementia: Possible relation to hypoperfusion. Neurobiol. Aging. 2001;22:195&#x2013;207. doi: 10.1016/S0197-4580(00)00231-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(00)00231-1</ArticleId><ArticleId IdType="pubmed">11182469</ArticleId></ArticleIdList></Reference><Reference><Citation>Broe M., Kril J., Halliday G.M. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain. 2004;127:2214&#x2013;2220. doi: 10.1093/brain/awh250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh250</ArticleId><ArticleId IdType="pubmed">15282215</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrits E., Giannini L.A.A., Brouwer N., Melhem S., Seilhean D., Le Ber I., Brainbank Neuro-CEB Neuropathology Network. Kamermans A., Kooij G., de Vries H.E., et al. Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex. Nat. Neurosci. 2022;25:1034&#x2013;1048. doi: 10.1038/s41593-022-01124-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01124-3</ArticleId><ArticleId IdType="pubmed">35879464</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsan E., Velmeshev D., Ramsey A., Patel R.K., Zhang J., Koontz M., Andrews M.G., de Majo M., Mora C., Blumenfeld J., et al. Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations. J. Clin. Investig. 2023;133:e164919. doi: 10.1172/JCI164919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI164919</ArticleId><ArticleId IdType="pmc">PMC10014110</ArticleId><ArticleId IdType="pubmed">36602862</ArticleId></ArticleIdList></Reference><Reference><Citation>Miedema S.S.M., Mol M.O., Koopmans F.T.W., Hondius D.C., van Nierop P., Menden K., de Veij Mestdagh C.F., van Rooij J., Ganz A.B., Paliukhovich I., et al. Distinct cell type-specific protein signatures in GRN and MAPT genetic subtypes of frontotemporal dementia. Acta Neuropathol. Commun. 2022;10:100. doi: 10.1186/s40478-022-01387-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01387-8</ArticleId><ArticleId IdType="pmc">PMC9261008</ArticleId><ArticleId IdType="pubmed">35799292</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisdall M.D., Ohm D.T., Lobrovich R., Das S.R., Mizsei G., Prabhakaran K., Ittyerah R., Lim S., McMillan C.T., Wolk D.A., et al. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology. Neuroimage Clin. 2022;33:102913. doi: 10.1016/j.nicl.2021.102913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2021.102913</ArticleId><ArticleId IdType="pmc">PMC8715243</ArticleId><ArticleId IdType="pubmed">34952351</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineda S.S., Lee H., Fitzwalter B.E., Mohammadi S., Pregent L.J., Gardashli M.E., Mantero J., Engelberg-Cook E., DeJesus-Hernandez M., van Blitterswijk M., et al. Single-cell profiling of the human primary motor cortex in ALS and FTLD. bioRxiv. 2021 doi: 10.1101/2021.07.07.451374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.07.451374</ArticleId></ArticleIdList></Reference><Reference><Citation>Limone F., Mordes D., Couto A., Pietil&#xe4;inen O., Joseph B.J., Burberry A., Ghosh S.D., Meyer D., Goldman M., Bortolin L., et al. Single-nucleus sequencing reveals enriched expression of genetic risk factors sensitises Motor Neurons to degeneration in ALS. bioRxiv. 2021 doi: 10.1101/2021.07.12.452054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.12.452054</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Bijnens B., Davie K., Poovathingal S.K., Storm A., Hersmus N., Fumagalli L., Van Den Bosch L., Fiers M., Thal D.R., et al. Hexanucleotide repeat expansions in C9orf72 alter microglial responses and prevent a coordinated glial reaction in ALS. bioRxiv. 2022 doi: 10.1101/2022.10.26.513909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.26.513909</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Jaiswal M.K., Chien J.-F., Kozlenkov A., Zhou P., Gardashli M., Pregent L.J., Engelberg-Cook E., Dickson D.W., Belzil V.V., et al. Divergent impacts of C9orf72 repeat expansion on neurons and glia in ALS and FTD. bioRxiv. 2022 doi: 10.1101/2022.11.17.516859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.17.516859</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.-L.V., Veire A.M., Gendron T.F., Gearing M., Glass J.D., Jin P., Corces V.G., McEachin Z.T. Single nucleus multiome analysis of the prefrontal cortex from C9orf72 ALS/FTD patients illuminates pathways affected during disease progression. bioRxiv. 2023 doi: 10.1101/2023.01.12.523820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.12.523820</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., Aijo T., Vickovic S., Braine C., Kang K., Mollbrink A., Fagegaltier D., Andrusivova Z., Saarenpaa S., Saiz-Castro G., et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory J.M., McDade K., Livesey M.R., Croy I., Marion de Proce S., Aitman T., Chandran S., Smith C. Spatial transcriptomics identifies spatially dysregulated expression of GRM3 and USP47 in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 2020;46:441&#x2013;457. doi: 10.1111/nan.12597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12597</ArticleId><ArticleId IdType="pubmed">31925813</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A., Engler H., Blomquist G., Scott B., Wall A., Aquilonius S.M., Langstrom B., Askmark H. Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET. J. Neurol. Sci. 2007;255:17&#x2013;22. doi: 10.1016/j.jns.2007.01.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.01.057</ArticleId><ArticleId IdType="pubmed">17346749</ArticleId></ArticleIdList></Reference><Reference><Citation>Taoka T., Masutani Y., Kawai H., Nakane T., Matsuoka K., Yasuno F., Kishimoto T., Naganawa S. Evaluation of glymphatic system activity with the diffusion MR technique: Diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer&#x2019;s disease cases. Jpn. J. Radiol. 2017;35:172&#x2013;178. doi: 10.1007/s11604-017-0617-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11604-017-0617-z</ArticleId><ArticleId IdType="pubmed">28197821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J.L., Wei Y.C., Toh C.H., Hsiao I.T., Lin K.J., Yen T.C., Liao M.F., Ro L.S. Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease. Ann. Neurol. 2022;93:164&#x2013;174. doi: 10.1002/ana.26516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26516</ArticleId><ArticleId IdType="pmc">PMC10091747</ArticleId><ArticleId IdType="pubmed">36214568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X., Chen Z., He C., Zhang P., Nie K., Qiu Y., Wang L., Wang L., Jing P., Zhang Y. Diffusion along perivascular spaces provides evidence interlinking compromised glymphatic function with aging in Parkinson&#x2019;s disease. CNS Neurosci. Ther. 2022;29:111&#x2013;121. doi: 10.1111/cns.13984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13984</ArticleId><ArticleId IdType="pmc">PMC9804035</ArticleId><ArticleId IdType="pubmed">36184792</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y., Abrahao A., Heyn C.C., Bethune A.J., Huang Y., Pople C.B., Aubert I., Hamani C., Zinman L., Hynynen K., et al. Glymphatics Visualization after Focused Ultrasound-Induced Blood-Brain Barrier Opening in Humans. Ann. Neurol. 2019;86:975&#x2013;980. doi: 10.1002/ana.25604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25604</ArticleId><ArticleId IdType="pubmed">31525269</ArticleId></ArticleIdList></Reference><Reference><Citation>Langen U.H., Ayloo S., Gu C. Development and Cell Biology of the Blood-Brain Barrier. Annu. Rev. Cell Dev. Biol. 2019;35:591&#x2013;613. doi: 10.1146/annurev-cellbio-100617-062608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100617-062608</ArticleId><ArticleId IdType="pmc">PMC8934576</ArticleId><ArticleId IdType="pubmed">31299172</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolski S., Nikoli&#x107; J., Bugarski-Prokopljevi&#x107; C., Mileti&#x107; V., Pavlovi&#x107; S., Filipovi&#x107; S. Serum and CSF immunological findings in ALS. Acta Neurol. Scand. 1991;83:96&#x2013;98. doi: 10.1111/j.1600-0404.1991.tb04656.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1991.tb04656.x</ArticleId><ArticleId IdType="pubmed">2017904</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.A., Sengillo J.D., Sullivan J.S., Henkel J.S., Appel S.H., Zlokovic B.V. Blood&#x2013;spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:111&#x2013;120. doi: 10.1007/s00401-012-1039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1039-8</ArticleId><ArticleId IdType="pmc">PMC3535352</ArticleId><ArticleId IdType="pubmed">22941226</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.-Y., Cai Z.-Y., Sun X.-H., Shen D.-c., Yang X.-Z., Liu M.-S., Cui L.-Y. Blood-brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia. Neurol. Sci. 2022;43:3201&#x2013;3210. doi: 10.1007/s10072-021-05731-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05731-z</ArticleId><ArticleId IdType="pubmed">34826032</ArticleId></ArticleIdList></Reference><Reference><Citation>Assialioui A., Dom&#xed;nguez R., Ferrer I., Andr&#xe9;s-Benito P., Povedano M. Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2022;23:11063. doi: 10.3390/ijms231911063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911063</ArticleId><ArticleId IdType="pmc">PMC9570498</ArticleId><ArticleId IdType="pubmed">36232365</ArticleId></ArticleIdList></Reference><Reference><Citation>Skillback T., Delsing L., Synnergren J., Mattsson N., Janelidze S., Nagga K., Kilander L., Hicks R., Wimo A., Winblad B., et al. CSF/serum albumin ratio in dementias: A cross-sectional study on 1861 patients. Neurobiol. Aging. 2017;59:1&#x2013;9. doi: 10.1016/j.neurobiolaging.2017.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.06.028</ArticleId><ArticleId IdType="pubmed">28779628</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Rumeileh S., Steinacker P., Polischi B., Mammana A., Bartoletti-Stella A., Oeckl P., Baiardi S., Zenesini C., Huss A., Cortelli P., et al. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia. Alzheimer&#x2019;s Res. Ther. 2019;12:2. doi: 10.1186/s13195-019-0562-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0562-4</ArticleId><ArticleId IdType="pmc">PMC6937795</ArticleId><ArticleId IdType="pubmed">31892365</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu L., An J., Kovalik T., Gendron T., Petrucelli L., Bowser R. Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes. J. Neurol. Neurosurg. Psychiatry. 2020;91:350&#x2013;358. doi: 10.1136/jnnp-2019-321916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321916</ArticleId><ArticleId IdType="pmc">PMC7147184</ArticleId><ArticleId IdType="pubmed">31937582</ArticleId></ArticleIdList></Reference><Reference><Citation>Woollacott I.O.C., Nicholas J.M., Heller C., Foiani M.S., Moore K.M., Russell L.L., Paterson R.W., Keshavan A., Schott J.M., Warren J.D., et al. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype. Dement. Geriatr. Cogn. Disord. 2020;49:56&#x2013;76. doi: 10.1159/000506282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000506282</ArticleId><ArticleId IdType="pmc">PMC7513620</ArticleId><ArticleId IdType="pubmed">32344399</ArticleId></ArticleIdList></Reference><Reference><Citation>Falzone Y.M., Domi T., Mandelli A., Pozzi L., Schito P., Russo T., Barbieri A., Fazio R., Volonte M.A., Magnani G., et al. Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis. Eur. J. Neurol. 2022;29:1930&#x2013;1939. doi: 10.1111/ene.15321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15321</ArticleId><ArticleId IdType="pmc">PMC9314044</ArticleId><ArticleId IdType="pubmed">35263489</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Milone I., Maranzano A., Colombo E., Torre S., Solca F., Doretti A., Gentile F., Manini A., Bonetti R., et al. Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2023;10:118&#x2013;129. doi: 10.1002/acn3.51708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51708</ArticleId><ArticleId IdType="pmc">PMC9852391</ArticleId><ArticleId IdType="pubmed">36525477</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Santos-Santos M., Ill&#xe1;n-Gala I., Montal V., Estell&#xe9;s T., Barroeta I., Altuna M., Arranz J., Mu&#xf1;oz L., Belbin O., et al. Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Transl. Neurodegener. 2021;10:50. doi: 10.1186/s40035-021-00275-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00275-w</ArticleId><ArticleId IdType="pmc">PMC8662866</ArticleId><ArticleId IdType="pubmed">34893073</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousins K.A.Q., Shaw L.M., Chen-Plotkin A., Wolk D.A., Van Deerlin V.M., Lee E.B., McMillan C.T., Grossman M., Irwin D.J. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers. JAMA Neurol. 2022;79:1155&#x2013;1164. doi: 10.1001/jamaneurol.2022.3265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.3265</ArticleId><ArticleId IdType="pmc">PMC9552044</ArticleId><ArticleId IdType="pubmed">36215050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez A.E., Gil-Jaramillo N., Tapias M.A., Gonzalez-Giraldo Y., Pinzon A., Puentes-Rozo P.J., Aristizabal-Pachon A.F., Gonzalez J. MicroRNA: A Linking between Astrocyte Dysfunction, Mild Cognitive Impairment, and Neurodegenerative Diseases. Life. 2022;12:1439. doi: 10.3390/life12091439.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12091439</ArticleId><ArticleId IdType="pmc">PMC9505027</ArticleId><ArticleId IdType="pubmed">36143475</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothhammer V., Mascanfroni I.D., Bunse L., Takenaka M.C., Kenison J.E., Mayo L., Chao C.C., Patel B., Yan R., Blain M., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 2016;22:586&#x2013;597. doi: 10.1038/nm.4106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4106</ArticleId><ArticleId IdType="pmc">PMC4899206</ArticleId><ArticleId IdType="pubmed">27158906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanmarco L.M., Wheeler M.A., Gutierrez-Vazquez C., Polonio C.M., Linnerbauer M., Pinho-Ribeiro F.A., Li Z., Giovannoni F., Batterman K.V., Scalisi G., et al. Gut-licensed IFNgamma(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes. Nature. 2021;590:473&#x2013;479. doi: 10.1038/s41586-020-03116-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03116-4</ArticleId><ArticleId IdType="pmc">PMC8039910</ArticleId><ArticleId IdType="pubmed">33408417</ArticleId></ArticleIdList></Reference><Reference><Citation>Margineanu M.B., Sherwin E., Golubeva A., Peterson V., Hoban A., Fiumelli H., Rea K., Cryan J.F., Magistretti P.J. Gut microbiota modulates expression of genes involved in the astrocyte-neuron lactate shuttle in the hippocampus. Eur. Neuropsychopharmacol. 2020;41:152&#x2013;159. doi: 10.1016/j.euroneuro.2020.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2020.11.006</ArticleId><ArticleId IdType="pubmed">33191074</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothhammer V., Borucki D.M., Tjon E.C., Takenaka M.C., Chao C.C., Ardura-Fabregat A., de Lima K.A., Gutierrez-Vazquez C., Hewson P., Staszewski O., et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018;557:724&#x2013;728. doi: 10.1038/s41586-018-0119-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0119-x</ArticleId><ArticleId IdType="pmc">PMC6422159</ArticleId><ArticleId IdType="pubmed">29769726</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S., Battistini C., Sun J. A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men. Front. Cell Infect. Microbiol. 2022;12:839526. doi: 10.3389/fcimb.2022.839526.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.839526</ArticleId><ArticleId IdType="pmc">PMC8963415</ArticleId><ArticleId IdType="pubmed">35360111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.S., Son J., Lee D., Tsai J., Wang D., Chocron E.S., Jeong S., Kittrell P., Murchison C.F., Kennedy R.E., et al. Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurol. 2022;22:62. doi: 10.1186/s12883-022-02586-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02586-5</ArticleId><ArticleId IdType="pmc">PMC8862222</ArticleId><ArticleId IdType="pubmed">35189854</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Wells M.F., Limone F., Couto A., Smith K.S., Keaney J., Gillet G., van Gastel N., Wang J.-Y., Pietilainen O., et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd T.W., Petrucelli L. Modelling amyotrophic lateral sclerosis in rodents. Nat. Rev. Neurosci. 2022;23:231&#x2013;251. doi: 10.1038/s41583-022-00564-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-022-00564-x</ArticleId><ArticleId IdType="pubmed">35260846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 2000;20:660&#x2013;665. doi: 10.1523/JNEUROSCI.20-02-00660.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-02-00660.2000</ArticleId><ArticleId IdType="pmc">PMC6772423</ArticleId><ArticleId IdType="pubmed">10632595</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003;302:113&#x2013;117. doi: 10.1126/science.1086071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086071</ArticleId><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadeas S.T., Kraig S.E., O&#x2019;Banion C., Lepore A.C., Maragakis N.J. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc. Natl. Acad. Sci. USA. 2011;108:17803&#x2013;17808. doi: 10.1073/pnas.1103141108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103141108</ArticleId><ArticleId IdType="pmc">PMC3203804</ArticleId><ArticleId IdType="pubmed">21969586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Qian K., Chen W., Hu B., Blackbourn L.W., 4th, Du Z., Ma L., Liu H., Knobel K.M., Ayala M., et al. Human-derived neural progenitors functionally replace astrocytes in adult mice. J. Clin. Investig. 2015;125:1033&#x2013;1042. doi: 10.1172/JCI69097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI69097</ArticleId><ArticleId IdType="pmc">PMC4362241</ArticleId><ArticleId IdType="pubmed">25642771</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J., Huang C., Bi F., Wu Q., Huang B., Liu X., Li F., Zhou H., Xia X.G. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 2013;32:1917&#x2013;1926. doi: 10.1038/emboj.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes P.S., Daniel S.G., McCallum A.P., Boehringer A.V., Sukhina A.S., Zwick R.A., Zarnescu D.C. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. Dis. Model. Mech. 2013;6:721&#x2013;733. doi: 10.1242/dmm.010710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.010710</ArticleId><ArticleId IdType="pmc">PMC3634655</ArticleId><ArticleId IdType="pubmed">23471911</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Wang H., Qiao T., Yang B., Aliaga L., Qiu L., Tan W., Salameh J., McKenna-Yasek D.M., Smith T., et al. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2014;111:E1121&#x2013;E1129. doi: 10.1073/pnas.1322641111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1322641111</ArticleId><ArticleId IdType="pmc">PMC3970502</ArticleId><ArticleId IdType="pubmed">24616503</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng A.Y.T., Agrawal I., Ho W.Y., Yen Y.-C., Pinter A.J., Liu J., Phua Q.X.C., Koh K.B., Chang J.-C., Sanford E., et al. Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction. Proc. Natl. Acad. Sci. USA. 2020;117:29101&#x2013;29112. doi: 10.1073/pnas.2007806117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2007806117</ArticleId><ArticleId IdType="pmc">PMC7682406</ArticleId><ArticleId IdType="pubmed">33127758</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen B.K., McAvoy K.J., Heinsinger N.M., Lepore A.C., Ilieva H., Haeusler A.R., Trotti D., Pasinelli P. Targeting TNFalpha produced by astrocytes expressing amyotrophic lateral sclerosis-linked mutant fused in sarcoma prevents neurodegeneration and motor dysfunction in mice. Glia. 2022;70:1426&#x2013;1449. doi: 10.1002/glia.24183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24183</ArticleId><ArticleId IdType="pmc">PMC9540310</ArticleId><ArticleId IdType="pubmed">35474517</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore A.C., Rauck B., Dejea C., Pardo A.C., Rao M.S., Rothstein J.D., Maragakis N.J. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 2008;11:1294&#x2013;1301. doi: 10.1038/nn.2210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2210</ArticleId><ArticleId IdType="pmc">PMC2656686</ArticleId><ArticleId IdType="pubmed">18931666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T., Funayama M., Tsukita K., Hotta A., Yasuda A., Nori S., Kaneko S., Nakamura M., Takahashi R., Okano H., et al. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Rep. 2014;3:242&#x2013;249. doi: 10.1016/j.stemcr.2014.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2014.05.017</ArticleId><ArticleId IdType="pmc">PMC4175543</ArticleId><ArticleId IdType="pubmed">25254338</ArticleId></ArticleIdList></Reference><Reference><Citation>Izrael M., Slutsky S.G., Admoni T., Cohen L., Granit A., Hasson A., Itskovitz-Eldor J., Krush Paker L., Kuperstein G., Lavon N., et al. Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1(G93A) and NSG animal models. Stem Cell Res. Ther. 2018;9:152. doi: 10.1186/s13287-018-0890-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-0890-5</ArticleId><ArticleId IdType="pmc">PMC5989413</ArticleId><ArticleId IdType="pubmed">29871694</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Risse E., Tyzack G.E., Mitchell J.S., Taha D.M., Chen Y.R., Newcombe J., Collinge J., Sidle K., Patani R. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Brain. 2020;143:430&#x2013;440. doi: 10.1093/brain/awz419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz419</ArticleId><ArticleId IdType="pmc">PMC7009461</ArticleId><ArticleId IdType="pubmed">32040555</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi P.M., Marrone L., Brasseur L., Coens A., Webster C.P., Bousset L., Destro M., Smith E.F., Walther C.G., Alfred V., et al. C9ORF72-derived poly-GA DPRs undergo endocytic uptake in iAstrocytes and spread to motor neurons. Life Sci. Alliance. 2022;5:e202101276. doi: 10.26508/lsa.202101276.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202101276</ArticleId><ArticleId IdType="pmc">PMC9108631</ArticleId><ArticleId IdType="pubmed">35568435</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz A., Pinheiro Marques J., Oertig I., Maharjan N., Saxena S. Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD. Front. Cell. Neurosci. 2021;15:637548. doi: 10.3389/fncel.2021.637548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.637548</ArticleId><ArticleId IdType="pmc">PMC7930069</ArticleId><ArticleId IdType="pubmed">33679328</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi D., Brambilla L., Valori C.F., Roncoroni C., Crugnola A., Yokota T., Bredesen D.E., Volterra A. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 2008;15:1691&#x2013;1700. doi: 10.1038/cdd.2008.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.99</ArticleId><ArticleId IdType="pubmed">18617894</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A., Bilican B., Barmada S.J., Ando D.M., Zhao C., Siller R., Burr K., Haghi G., Story D., Nishimura A.L., et al. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc. Natl. Acad. Sci. USA. 2013;110:4697&#x2013;4702. doi: 10.1073/pnas.1300398110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300398110</ArticleId><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall C.E., Yao Z., Choi M., Tyzack G.E., Serio A., Luisier R., Harley J., Preza E., Arber C., Crisp S.J., et al. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS. Cell Rep. 2017;19:1739&#x2013;1749. doi: 10.1016/j.celrep.2017.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.024</ArticleId><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Hall B., Castelli L.M., Francis L., Woof R., Siskos A.P., Kouloura E., Gray E., Thompson A.G., Talbot K., et al. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain. 2019;142:586&#x2013;605. doi: 10.1093/brain/awy353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy353</ArticleId><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.P., Hall B., Woof R., Francis L., Gatto N., Shaw A.C., Myszczynska M., Hemingway J., Coldicott I., Willcock A., et al. C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain. 2019;142:3771&#x2013;3790. doi: 10.1093/brain/awz302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz302</ArticleId><ArticleId IdType="pmc">PMC6906594</ArticleId><ArticleId IdType="pubmed">31647549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallmann A.L., Arauzo-Bravo M.J., Mavrommatis L., Ehrlich M., Ropke A., Brockhaus J., Missler M., Sterneckert J., Scholer H.R., Kuhlmann T., et al. Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein. Sci. Rep. 2017;7:42991. doi: 10.1038/srep42991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42991</ArticleId><ArticleId IdType="pmc">PMC5335603</ArticleId><ArticleId IdType="pubmed">28256506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahali S., Karch C. Defective proteostasis in patient-derived iPSC-astrocytes and neurons carrying a MAPT IVS10+16 mutation. Alzheimer&#x2019;s Dement. 2021;17:e058727. doi: 10.1002/alz.058727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.058727</ArticleId></ArticleIdList></Reference><Reference><Citation>Szebenyi K., Wenger L.M.D., Sun Y., Dunn A.W.E., Limegrover C.A., Gibbons G.M., Conci E., Paulsen O., Mierau S.B., Balmus G., et al. Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nat. Neurosci. 2021;24:1542&#x2013;1554. doi: 10.1038/s41593-021-00923-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00923-4</ArticleId><ArticleId IdType="pmc">PMC8553627</ArticleId><ArticleId IdType="pubmed">34675437</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekaran A., Dittlau K.S., Corsi G.I., Haukedal H., Doncheva N.T., Ramakrishna S., Ambardar S., Salcedo C., Schmidt S.I., Zhang Y., et al. Astrocytic reactivity triggered by defective autophagy and metabolic failure causes neurotoxicity in frontotemporal dementia type 3. Stem Cell Rep. 2021;16:2736&#x2013;2751. doi: 10.1016/j.stemcr.2021.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.09.013</ArticleId><ArticleId IdType="pmc">PMC8581052</ArticleId><ArticleId IdType="pubmed">34678206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Guan Y., Liu H., Wu X., Yu L., Wang S., Zhao C., Du H., Wang X. Activation of the Wnt/beta-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem. Biophys. Res. Commun. 2012;420:397&#x2013;403. doi: 10.1016/j.bbrc.2012.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.03.006</ArticleId><ArticleId IdType="pubmed">22426476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepore A.C., Dejea C., Carmen J., Rauck B., Kerr D.A., Sofroniew M.V., Maragakis N.J. Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration. Exp. Neurol. 2008;211:423&#x2013;432. doi: 10.1016/j.expneurol.2008.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2008.02.020</ArticleId><ArticleId IdType="pmc">PMC9152669</ArticleId><ArticleId IdType="pubmed">18410928</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Martinez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Komine O., Yamashita H., Fujimori-Tonou N., Koike M., Jin S., Moriwaki Y., Endo F., Watanabe S., Uematsu S., Akira S., et al. Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes. Cell Death Differ. 2018;25:2130&#x2013;2146. doi: 10.1038/s41418-018-0098-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0098-3</ArticleId><ArticleId IdType="pmc">PMC6261996</ArticleId><ArticleId IdType="pubmed">29568058</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergouts M., Doyen P.J., Peeters M., Opsomer R., Hermans E. Constitutive downregulation protein kinase C epsilon in hSOD1(G93A) astrocytes influences mGluR5 signaling and the regulation of glutamate uptake. Glia. 2018;66:749&#x2013;761. doi: 10.1002/glia.23279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23279</ArticleId><ArticleId IdType="pubmed">29266405</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad A.A., Doreswamy A., Gross S.K., Richard J.P., Huo Y., Haughey N., Maragakis N.J. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis. Glia. 2016;64:1154&#x2013;1169. doi: 10.1002/glia.22989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22989</ArticleId><ArticleId IdType="pmc">PMC5635605</ArticleId><ArticleId IdType="pubmed">27083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H., Ng S.K., Diaz N., Burstein S., Morel L., Osgood A., Sider B., Higashimori H., Haydon P.G., Manfredi G., et al. Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J. Neurosci. 2014;34:2331&#x2013;2348. doi: 10.1523/JNEUROSCI.2689-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2689-13.2014</ArticleId><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Norante R.P., Peggion C., Rossi D., Martorana F., De Mario A., Lia A., Massimino M.L., Bertoli A. ALS-Associated SOD1(G93A) Decreases SERCA Pump Levels and Increases Store-Operated Ca2+ Entry in Primary Spinal Cord Astrocytes from a Transgenic Mouse Model. Int. J. Mol. Sci. 2019;20:5151. doi: 10.3390/ijms20205151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205151</ArticleId><ArticleId IdType="pmc">PMC6829245</ArticleId><ArticleId IdType="pubmed">31627428</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa M., Gomes C., Sequeira C., Gon&#xe7;alves-Ribeiro J., Pina C.C., Carvalho L.A., Moreira R., Vaz S.H., Vaz A.R., Brites D. Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons. Front. Cell Dev. Biol. 2021;9 doi: 10.3389/fcell.2021.634355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.634355</ArticleId><ArticleId IdType="pmc">PMC8103001</ArticleId><ArticleId IdType="pubmed">33968923</ArticleId></ArticleIdList></Reference><Reference><Citation>Milosevic M., Bataveljic D., Nikolic L., Bijelic D., Andjus P. The effect of amyotrophic lateral sclerosis-linked exogenous SOD1-G93A on electrophysiological properties and intracellular calcium in cultured rat astrocytes. Amyotroph Lateral Scler Front. Degener. 2016;17:443&#x2013;451. doi: 10.3109/21678421.2016.1143516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1143516</ArticleId><ArticleId IdType="pubmed">26892977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim D., Dematteis G., Tapella L., Genazzani A.A., Cali T., Brini M., Verkhratsky A. Ca(2+) handling at the mitochondria-ER contact sites in neurodegeneration. Cell Calcium. 2021;98:102453. doi: 10.1016/j.ceca.2021.102453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2021.102453</ArticleId><ArticleId IdType="pubmed">34399235</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker D.J., Blackburn D.J., Keatinge M., Sokhi D., Viskaitis P., Heath P.R., Ferraiuolo L., Kirby J., Shaw P.J. Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Front. Cell Neurosci. 2015;9:410. doi: 10.3389/fncel.2015.00410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00410</ArticleId><ArticleId IdType="pmc">PMC4606544</ArticleId><ArticleId IdType="pubmed">26528138</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S.J., Glatzer J.C., Hsieh Y.-C., Rothstein J.D. Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model. J. Neurogenet. 2018;32:322&#x2013;335. doi: 10.1080/01677063.2018.1513508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01677063.2018.1513508</ArticleId><ArticleId IdType="pmc">PMC6444185</ArticleId><ArticleId IdType="pubmed">30398075</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S.J., Zhang P.-W., Glatzer J., Rothstein J.D. Astroglial transcriptome dysregulation in early disease of an ALS mutant SOD1 mouse model. J. Neurogenet. 2017;31:37&#x2013;48. doi: 10.1080/01677063.2016.1260128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01677063.2016.1260128</ArticleId><ArticleId IdType="pubmed">28019127</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Venugopal S., Majid S., Ahn I.S., Diamante G., Hong J., Yang X., Chandler S.H. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis. Neurobiol. Dis. 2020;141:104877. doi: 10.1016/j.nbd.2020.104877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104877</ArticleId><ArticleId IdType="pmc">PMC7519882</ArticleId><ArticleId IdType="pubmed">32360664</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Meyer K., Sherwood T.W., Vick J., Likhite S., Frakes A., Miranda C.J., Braun L., Heath P.R., Pineda R., et al. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc. Natl. Acad. Sci. USA. 2016;113:E6496&#x2013;E6505. doi: 10.1073/pnas.1607496113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha D.M., Clarke B.E., Hall C.E., Tyzack G.E., Ziff O.J., Greensmith L., Kalmar B., Ahmed M., Alam A., Thelin E.P., et al. Astrocytes display cell autonomous and diverse early reactive states in familial amyotrophic lateral sclerosis. Brain. 2022;145:481&#x2013;489. doi: 10.1093/brain/awab328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab328</ArticleId><ArticleId IdType="pmc">PMC9014746</ArticleId><ArticleId IdType="pubmed">35042241</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles K.R., Silva M.C., Whitney K., Bertucci T., Berlind J.E., Lai J.D., Garza J.C., Boles N.C., Mahali S., Strang K.H., et al. ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids. Cell. 2021;184:4547&#x2013;4563. doi: 10.1016/j.cell.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8635409</ArticleId><ArticleId IdType="pubmed">34314701</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasauer S.M.K., Goderie S.K., Rauch J.N., Guzman E., Audouard M., Bertucci T., Joy S., Rommelfanger E., Luna G., Keane-Rivera E., et al. Human tau mutations in cerebral organoids induce a progressive dyshomeostasis of cholesterol. Stem Cell Rep. 2022;17:2127&#x2013;2140. doi: 10.1016/j.stemcr.2022.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.07.011</ArticleId><ArticleId IdType="pmc">PMC9481908</ArticleId><ArticleId IdType="pubmed">35985329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff O.J., Clarke B.E., Taha D.M., Crerar H., Luscombe N.M., Patani R. Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states. Genome Res. 2022;32:71&#x2013;84. doi: 10.1101/gr.275939.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.275939.121</ArticleId><ArticleId IdType="pmc">PMC8744676</ArticleId><ArticleId IdType="pubmed">34963663</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan K.A., Weigel M.K., Adler D.I., Couthouis J., Liddelow S.A., Gitler A.D., Barres B.A. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat. Commun. 2020;11:3753. doi: 10.1038/s41467-020-17514-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17514-9</ArticleId><ArticleId IdType="pmc">PMC7385161</ArticleId><ArticleId IdType="pubmed">32719333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V., Re D.B., Le Verche V., Alvarez M.J., Vasciaveo A., Jacquier A., Doulias P.T., Greco T.M., Nizzardo M., Papadimitriou D., et al. Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow. Nat. Commun. 2020;11:5579. doi: 10.1038/s41467-020-19177-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19177-y</ArticleId><ArticleId IdType="pmc">PMC7642391</ArticleId><ArticleId IdType="pubmed">33149111</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng K., Rose I.V.L., Kim H., Xia W., Romero-Fernandez W., Rooney B., Koontz M., Li E., Ao Y., Wang S., et al. CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states. Nat. Neurosci. 2022;25:1528&#x2013;1542. doi: 10.1038/s41593-022-01180-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01180-9</ArticleId><ArticleId IdType="pmc">PMC9633461</ArticleId><ArticleId IdType="pubmed">36303069</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Hall C.E., Sibley C.R., Cymes T., Forostyak S., Carlino G., Meyer I.F., Schiavo G., Zhang S.C., Gibbons G.M., et al. A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat. Commun. 2017;8:1164. doi: 10.1038/s41467-017-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01283-z</ArticleId><ArticleId IdType="pmc">PMC5660125</ArticleId><ArticleId IdType="pubmed">29079839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Leng K., Park J., Sorets A.G., Kim S., Shostak A., Embalabala R.J., Mlouk K., Katdare K.A., Rose I.V.L., et al. Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin. Nat. Commun. 2022;13:6581. doi: 10.1038/s41467-022-34412-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34412-4</ArticleId><ArticleId IdType="pmc">PMC9630454</ArticleId><ArticleId IdType="pubmed">36323693</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales J.E., De A., Miller A.A., Chen Z., McCarty J.H. Mlc1-Expressing Perivascular Astrocytes Promote Blood&#x2013;Brain Barrier Integrity. J. Neurosci. 2022;42:1406&#x2013;1416. doi: 10.1523/JNEUROSCI.1918-21.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1918-21.2021</ArticleId><ArticleId IdType="pmc">PMC8883848</ArticleId><ArticleId IdType="pubmed">34965971</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Bender D.E., Delaney C.E., Cataldo M.D., Smith A.L., Yung R., Ruden D.M., Callaghan B.C., Feldman E.L. Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis. PLoS ONE. 2012;7:e52672. doi: 10.1371/journal.pone.0052672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052672</ArticleId><ArticleId IdType="pmc">PMC3530456</ArticleId><ArticleId IdType="pubmed">23300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignone M.S., Lanciotti A., Serafini B., Mallozzi C., Sbriccoli M., Veroni C., Molinari P., Elorza-Vidal X., Petrucci T.C., Estevez R., et al. Megalencephalic Leukoencephalopathy with Subcortical Cysts Protein-1 (MLC1) Counteracts Astrocyte Activation in Response to Inflammatory Signals. Mol. Neurobiol. 2019;56:8237&#x2013;8254. doi: 10.1007/s12035-019-01657-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01657-y</ArticleId><ArticleId IdType="pubmed">31209783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanciotti A., Brignone M.S., Belfiore M., Columba-Cabezas S., Mallozzi C., Vincentini O., Molinari P., Petrucci T.C., Visentin S., Ambrosini E. Megalencephalic Leukoencephalopathy with Subcortical Cysts Disease-Linked MLC1 Protein Favors Gap-Junction Intercellular Communication by Regulating Connexin 43 Trafficking in Astrocytes. Cells. 2020;9:1425. doi: 10.3390/cells9061425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9061425</ArticleId><ArticleId IdType="pmc">PMC7348769</ArticleId><ArticleId IdType="pubmed">32521795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Sun Y., Ling S.C., Ferraiuolo L., McAlonis-Downes M., Zou Y., Drenner K., Wang Y., Ditsworth D., Tokunaga S., et al. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc. Natl. Acad. Sci. USA. 2015;112:E6993&#x2013;E7002. doi: 10.1073/pnas.1520639112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1520639112</ArticleId><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella R., Bonadio R.S., Cagnin S., Massimino M.L., Bertoli A., Peggion C. Perturbations of the Proteome and of Secreted Metabolites in Primary Astrocytes from the hSOD1(G93A) ALS Mouse Model. Int. J. Mol. Sci. 2021;22:7028. doi: 10.3390/ijms22137028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22137028</ArticleId><ArticleId IdType="pmc">PMC8268687</ArticleId><ArticleId IdType="pubmed">34209958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Higginbottom A., Heath P.R., Barber S., Greenald D., Kirby J., Shaw P.J. Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain. 2011;134:2627&#x2013;2641. doi: 10.1093/brain/awr193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr193</ArticleId><ArticleId IdType="pmc">PMC3170534</ArticleId><ArticleId IdType="pubmed">21908873</ArticleId></ArticleIdList></Reference><Reference><Citation>Madji Hounoum B., Mavel S., Coque E., Patin F., Vourc&#x2019;h P., Marouillat S., Nadal-Desbarats L., Emond P., Corcia P., Andres C.R., et al. Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling. Glia. 2017;65:592&#x2013;605. doi: 10.1002/glia.23114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23114</ArticleId><ArticleId IdType="pubmed">28139855</ArticleId></ArticleIdList></Reference><Reference><Citation>Egawa N., Izumi Y., Suzuki H., Tsuge I., Fujita K., Shimano H., Izumikawa K., Takahashi N., Tsukita K., Enami T., et al. TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2. Sci. Rep. 2022;12:7988. doi: 10.1038/s41598-022-12133-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-12133-4</ArticleId><ArticleId IdType="pmc">PMC9107471</ArticleId><ArticleId IdType="pubmed">35568729</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M., Vallarola A., Lidonnici D., Battaglia E., Gensano F., Spaltro G., Fiordaliso F., Corbelli A., Garetto S., Martini E., et al. Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression. J. Neurochem. 2015;135:109&#x2013;124. doi: 10.1111/jnc.13154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13154</ArticleId><ArticleId IdType="pubmed">25940956</ArticleId></ArticleIdList></Reference><Reference><Citation>Phatnani H.P., Guarnieri P., Friedman B.A., Carrasco M.A., Muratet M., O&#x2019;Keeffe S., Nwakeze C., Pauli-Behn F., Newberry K.M., Meadows S.K., et al. Intricate interplay between astrocytes and motor neurons in ALS. Proc. Natl. Acad. Sci. USA. 2013;110:E756&#x2013;E765. doi: 10.1073/pnas.1222361110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222361110</ArticleId><ArticleId IdType="pmc">PMC3581928</ArticleId><ArticleId IdType="pubmed">23388633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A., McAvoy K., Krishnamurthy K., Trotti D., Pasinelli P. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia. 2018;66:1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 2007;10:608&#x2013;614. doi: 10.1038/nn1885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland L.G., Nirmalananthan N., Yip J., Greensmith L., Duchen M.R. Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria. J. Neurochem. 2008;107:1271&#x2013;1283. doi: 10.1111/j.1471-4159.2008.05699.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05699.x</ArticleId><ArticleId IdType="pubmed">18808448</ArticleId></ArticleIdList></Reference><Reference><Citation>Provenzano F., Nyberg S., Giunti D., Torazza C., Parodi B., Bonifacino T., Usai C., Kerlero de Rosbo N., Milanese M., Uccelli A., et al. Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS. Cells. 2022;11:3923. doi: 10.3390/cells11233923.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11233923</ArticleId><ArticleId IdType="pmc">PMC9741322</ArticleId><ArticleId IdType="pubmed">36497181</ArticleId></ArticleIdList></Reference><Reference><Citation>Re D.B., Le Verche V., Yu C., Amoroso M.W., Politi K.A., Phani S., Ikiz B., Hoffmann L., Koolen M., Nagata T., et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001&#x2013;1008. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., Ferraiuolo L., Miranda C.J., Likhite S., McElroy S., Renusch S., Ditsworth D., Lagier-Tourenne C., Smith R.A., Ravits J., et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. USA. 2014;111:829&#x2013;832. doi: 10.1073/pnas.1314085111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto M.C., Muotri A.R., Mu Y., Smith A.M., Cezar G.G., Gage F.H. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell. 2008;3:649&#x2013;657. doi: 10.1016/j.stem.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Boulting G.L., Bobrowicz S., Eggan K.C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell. 2008;3:637&#x2013;648. doi: 10.1016/j.stem.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.09.017</ArticleId><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S., Miranda C.J., Braun L., Meyer K., Frakes A.E., Ferraiuolo L., Likhite S., Bevan A.K., Foust K.D., McConnell M.J., et al. Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nat. Med. 2016;22:397&#x2013;403. doi: 10.1038/nm.4052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4052</ArticleId><ArticleId IdType="pmc">PMC4823173</ArticleId><ArticleId IdType="pubmed">26928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikiz B., Alvarez M.J., R&#xe9; D.B., Le Verche V., Politi K., Lotti F., Phani S., Pradhan R., Yu C., Croft G.F., et al. The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis. Cell Rep. 2015;12:335&#x2013;345. doi: 10.1016/j.celrep.2015.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.06.019</ArticleId><ArticleId IdType="pmc">PMC4646662</ArticleId><ArticleId IdType="pubmed">26146077</ArticleId></ArticleIdList></Reference><Reference><Citation>Arredondo C., Cefaliello C., Dyrda A., Jury N., Martinez P., D&#xed;az I., Amaro A., Tran H., Morales D., Pertusa M., et al. Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons. Neuron. 2022;110:1656&#x2013;1670. doi: 10.1016/j.neuron.2022.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.02.010</ArticleId><ArticleId IdType="pmc">PMC9119918</ArticleId><ArticleId IdType="pubmed">35276083</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz E., Izaurieta P., Weiss A., Mir F.R., Rojas P., Gonzalez D., Rojas F., Brown R.H., Jr., Madrid R., van Zundert B. Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability. J. Neurophysiol. 2013;109:2803&#x2013;2814. doi: 10.1152/jn.00500.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00500.2012</ArticleId><ArticleId IdType="pmc">PMC3680799</ArticleId><ArticleId IdType="pubmed">23486205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Jarquin U.N., Rojas F., van Zundert B., Tapia R. Chronic infusion of SOD1(G93A) astrocyte-secreted factors induces spinal motoneuron degeneration and neuromuscular dysfunction in healthy rats. J. Cell Physiol. 2017;232:2610&#x2013;2615. doi: 10.1002/jcp.25827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25827</ArticleId><ArticleId IdType="pubmed">28128448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F., Cortes N., Abarzua S., Dyrda A., van Zundert B. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front. Cell Neurosci. 2014;8:24. doi: 10.3389/fncel.2014.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00024</ArticleId><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F., Gonzalez D., Cortes N., Ampuero E., Hernandez D.E., Fritz E., Abarzua S., Martinez A., Elorza A.A., Alvarez A., et al. Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling. Front. Cell Neurosci. 2015;9:203. doi: 10.3389/fncel.2015.00203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00203</ArticleId><ArticleId IdType="pmc">PMC4460879</ArticleId><ArticleId IdType="pubmed">26106294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kim S., Kang H.-Y., Lim H.R., Kwon Y., Jo M., Jeon Y.-M., Kim S.R., Kim K., Ha C.M., et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J. Neuroinflamm. 2020;17:299. doi: 10.1186/s12974-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker J.M., Kr&#xfc;ger L., Sydow A., Dennissen F.J., Siskova Z., Mandelkow E., Mandelkow E.-M. The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity. EMBO Rep. 2016;17:552&#x2013;569. doi: 10.15252/embr.201541439.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541439</ArticleId><ArticleId IdType="pmc">PMC4818782</ArticleId><ArticleId IdType="pubmed">26931569</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldana B.I., Zhang Y., Jensen P., Chandrasekaran A., Christensen S.K., Nielsen T.T., Nielsen J.E., Hyttel P., Larsen M.R., Waagepetersen H.S., et al. Glutamate-glutamine homeostasis is perturbed in neurons and astrocytes derived from patient iPSC models of frontotemporal dementia. Mol. Brain. 2020;13:125. doi: 10.1186/s13041-020-00658-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-00658-6</ArticleId><ArticleId IdType="pmc">PMC7491073</ArticleId><ArticleId IdType="pubmed">32928252</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennys C.N., Roussel F., Rodrigo R., Zhang X., Sierra Delgado A., Hartlaub A., Saelim-Ector A., Ray W., Heintzman S., Fox A., et al. CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis. Glia. 2022;71:350&#x2013;365. doi: 10.1002/glia.24278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24278</ArticleId><ArticleId IdType="pmc">PMC10092379</ArticleId><ArticleId IdType="pubmed">36213964</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Cunha C., Nascimento F., Ribeiro J.A., Vaz A.R., Brites D. Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model. Mol. Neurobiol. 2019;56:2137&#x2013;2158. doi: 10.1007/s12035-018-1220-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1220-8</ArticleId><ArticleId IdType="pubmed">29995256</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Sequeira C., Likhite S., Dennys C.N., Kolb S.J., Shaw P.J., Vaz A.R., Kaspar B.K., Meyer K., Brites D. Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes. Cells. 2022;11:1186. doi: 10.3390/cells11071186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071186</ArticleId><ArticleId IdType="pmc">PMC8997588</ArticleId><ArticleId IdType="pubmed">35406750</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba R., Sorensen D.L., Booth S.A. MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response. Front. Immunol. 2014;5:578. doi: 10.3389/fimmu.2014.00578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00578</ArticleId><ArticleId IdType="pmc">PMC4240164</ArticleId><ArticleId IdType="pubmed">25484882</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A., Myszczynska M.A., Castelli L.M., O&#x2019;Neill B., Kim Y., Talbot J., Nyberg S., Nyamali I., Heath P.R., Stopford M.J., et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. eBioMedicine. 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.-T., Wang H.-Z., Wu Z.-W., Yang T.-Q., Zhao Z.-H., Chen G.-L., Xie X.-S., Li B., Wei Y.-X., Huang Y.-l., et al. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Cell. Mol. Neurobiol. 2015;35:679&#x2013;687. doi: 10.1007/s10571-015-0163-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0163-0</ArticleId><ArticleId IdType="pmc">PMC4477718</ArticleId><ArticleId IdType="pubmed">25662849</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D.J., Wang X.L., Ismail A., Ashman C.J., Valori C.F., Wang G., Gao S., Higginbottom A., Ince P.G., Azzouz M., et al. PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons. Cell Death Dis. 2014;5:e1096. doi: 10.1038/cddis.2014.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.55</ArticleId><ArticleId IdType="pmc">PMC3944269</ArticleId><ArticleId IdType="pubmed">24577094</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., He K., Zhou W., Cao J., Jin Z. miR-494-3p regulates lipopolysaccharide-induced inflammatory responses in RAW264.7 cells by targeting PTEN. Mol. Med. Rep. 2019;19:4288&#x2013;4296. doi: 10.3892/mmr.2019.10083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10083</ArticleId><ArticleId IdType="pmc">PMC6471187</ArticleId><ArticleId IdType="pubmed">30942409</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan K.A., Weigel M.K., Prakash P., Wijewardhane P.R., Hasel P., Rufen-Blanchette U., M&#xfc;nch A.E., Blum J.A., Fine J., Neal M.C., et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. 2021;599:102&#x2013;107. doi: 10.1038/s41586-021-03960-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03960-y</ArticleId><ArticleId IdType="pubmed">34616039</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffaele S., Boccazzi M., Fumagalli M. Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives. Cells. 2021;10:565. doi: 10.3390/cells10030565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030565</ArticleId><ArticleId IdType="pmc">PMC8000560</ArticleId><ArticleId IdType="pubmed">33807572</ArticleId></ArticleIdList></Reference><Reference><Citation>Traiffort E., Morisset-Lopez S., Moussaed M., Zahaf A. Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2021;22:3426. doi: 10.3390/ijms22073426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073426</ArticleId><ArticleId IdType="pmc">PMC8036314</ArticleId><ArticleId IdType="pubmed">33810425</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori C.F., Neumann M. Contribution of RNA/DNA Binding Protein Dysfunction in Oligodendrocytes in the Pathogenesis of the Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration Spectrum Diseases. Front Neurosci. 2021;15:724891. doi: 10.3389/fnins.2021.724891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.724891</ArticleId><ArticleId IdType="pmc">PMC8440855</ArticleId><ArticleId IdType="pubmed">34539339</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Hernandez-Ontiveros D.G., Rodrigues M.C., Haller E., Frisina-Deyo A., Mirtyl S., Sallot S., Saporta S., Borlongan C.V., Sanberg P.R. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114&#x2013;128. doi: 10.1016/j.brainres.2012.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.05.056</ArticleId><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Saporta S., Haller E., Kolomey I., Bennett S.P., Potter H., Sanberg P.R. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE. 2007;2:e1205. doi: 10.1371/journal.pone.0001205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001205</ArticleId><ArticleId IdType="pmc">PMC2075163</ArticleId><ArticleId IdType="pubmed">18030339</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Haller E., Saporta S., Kolomey I., Nicosia S.V., Sanberg P.R. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 2007;1157:126&#x2013;137. doi: 10.1016/j.brainres.2007.04.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.04.044</ArticleId><ArticleId IdType="pubmed">17512910</ArticleId></ArticleIdList></Reference><Reference><Citation>Milane A., Fernandez C., Dupuis L., Buyse M., Loeffler J.P., Farinotti R., Meininger V., Bensimon G. P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis. Neurosci. Lett. 2010;472:166&#x2013;170. doi: 10.1016/j.neulet.2010.01.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2010.01.078</ArticleId><ArticleId IdType="pubmed">20138122</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamenkovic S., Pavicevic A., Mojovic M., Popovic-Bijelic A., Selakovic V., Andjus P., Bacic G. In vivo EPR pharmacokinetic evaluation of the redox status and the blood brain barrier permeability in the SOD1(G93A) ALS rat model. Free Radic. Biol. Med. 2017;108:258&#x2013;269. doi: 10.1016/j.freeradbiomed.2017.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.03.034</ArticleId><ArticleId IdType="pubmed">28366802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z., Deane R., Ali Z., Parisi M., Shapovalov Y., O&#x2019;Banion M.K., Stojanovic K., Sagare A., Boillee S., Cleveland D.W., et al. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 2008;11:420&#x2013;422. doi: 10.1038/nn2073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2073</ArticleId><ArticleId IdType="pmc">PMC2895310</ArticleId><ArticleId IdType="pubmed">18344992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicaise C., Mitrecic D., Demetter P., De Decker R., Authelet M., Boom A., Pochet R. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res. 2009;1301:152&#x2013;162. doi: 10.1016/j.brainres.2009.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.09.018</ArticleId><ArticleId IdType="pubmed">19748495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamudio F., Loon A.R., Smeltzer S., Benyamine K., Navalpur Shanmugam N.K., Stewart N.J.F., Lee D.C., Nash K., Selenica M.-L.B. TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model. J. Neuroinflamm. 2020;17:283. doi: 10.1186/s12974-020-01952-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01952-9</ArticleId><ArticleId IdType="pmc">PMC7519496</ArticleId><ArticleId IdType="pubmed">32979923</ArticleId></ArticleIdList></Reference><Reference><Citation>Jablonski M.R., Jacob D.A., Campos C., Miller D.S., Maragakis N.J., Pasinelli P., Trotti D. Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS. Neurobiol. Dis. 2012;47:194&#x2013;200. doi: 10.1016/j.nbd.2012.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.03.040</ArticleId><ArticleId IdType="pmc">PMC3367047</ArticleId><ArticleId IdType="pubmed">22521463</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed L.A., Markandaiah S.S., Bonanno S., Pasinelli P., Trotti D. Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis. Exp. Neurol. 2019;316:27&#x2013;38. doi: 10.1016/j.expneurol.2019.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2019.04.002</ArticleId><ArticleId IdType="pmc">PMC6506236</ArticleId><ArticleId IdType="pubmed">30974102</ArticleId></ArticleIdList></Reference><Reference><Citation>Qosa H., Lichter J., Sarlo M., Markandaiah S.S., McAvoy K., Richard J.-P., Jablonski M.R., Maragakis N.J., Pasinelli P., Trotti D. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood&#x2013;brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis. Glia. 2016;64:1298&#x2013;1313. doi: 10.1002/glia.23003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23003</ArticleId><ArticleId IdType="pmc">PMC5541958</ArticleId><ArticleId IdType="pubmed">27158936</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe-Matsumoto S., Moriwaki Y., Okuda T., Ohara S., Yamanaka K., Abe Y., Yasui M., Misawa H. Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis. Neurosci. Res. 2018;133:48&#x2013;57. doi: 10.1016/j.neures.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.11.001</ArticleId><ArticleId IdType="pubmed">29154923</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicaise C., Soyfoo M.S., Authelet M., De Decker R., Bataveljic D., Delporte C., Pochet R. Aquaporin-4 overexpression in rat ALS model. Anat. Rec. (Hoboken) 2009;292:207&#x2013;213. doi: 10.1002/ar.20838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.20838</ArticleId><ArticleId IdType="pubmed">19089902</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y., Kuta R., Grasmuck C., Prat A., Durham H.D., Vande Velde C. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci. Rep. 2018;8:7551. doi: 10.1038/s41598-018-25767-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25767-0</ArticleId><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J., Lin W., Zheng M., Liu Q., He B., Luo C., Lu X., Pei Z., Su H., Yao X. Alterations in AQP4 expression and polarization in the course of motor neuron degeneration in SOD1G93A mice. Mol. Med. Rep. 2017;16:1739&#x2013;1746. doi: 10.3892/mmr.2017.6786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6786</ArticleId><ArticleId IdType="pmc">PMC5562093</ArticleId><ArticleId IdType="pubmed">28627708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bataveljic D., Nikolic L., Milosevic M., Todorovic N., Andjus P.R. Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model. Glia. 2012;60:1991&#x2013;2003. doi: 10.1002/glia.22414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22414</ArticleId><ArticleId IdType="pubmed">22987392</ArticleId></ArticleIdList></Reference><Reference><Citation>Mader S., Brimberg L. Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease. Cells. 2019;8:90. doi: 10.3390/cells8020090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8020090</ArticleId><ArticleId IdType="pmc">PMC6406241</ArticleId><ArticleId IdType="pubmed">30691235</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen G.M., Avalos P., Ma A.A., Alkaslasi M., Cho N., Wyss L., Vit J.P., Godoy M., Suezaki P., Shelest O., et al. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis. Stem Cells. 2018;36:1122&#x2013;1131. doi: 10.1002/stem.2825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2825</ArticleId><ArticleId IdType="pubmed">29656478</ArticleId></ArticleIdList></Reference><Reference><Citation>Brambilla L., Guidotti G., Martorana F., Iyer A.M., Aronica E., Valori C.F., Rossi D. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2016;25:3080&#x2013;3095. doi: 10.1093/hmg/ddw161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw161</ArticleId><ArticleId IdType="pubmed">27288458</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh R.H., Johnson J.P., Avalos P., Allred P., Svendsen S., Gowing G., Roxas K., Wu A., Donahue B., Osborne S., et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: A phase 1/2a trial. Nat. Med. 2022;28:1813&#x2013;1822. doi: 10.1038/s41591-022-01956-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01956-3</ArticleId><ArticleId IdType="pmc">PMC9499868</ArticleId><ArticleId IdType="pubmed">36064599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Gutmann D.H., Roos R.P. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum. Mol. Genet. 2011;20:286&#x2013;293. doi: 10.1093/hmg/ddq463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq463</ArticleId><ArticleId IdType="pubmed">20962037</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Foust K.D., Salazar D.L., Likhite S., Ferraiuolo L., Ditsworth D., Ilieva H., Meyer K., Schmelzer L., Braun L., Cleveland D.W., et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol. Ther. 2013;21:2148&#x2013;2159. doi: 10.1038/mt.2013.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.211</ArticleId><ArticleId IdType="pmc">PMC3863799</ArticleId><ArticleId IdType="pubmed">24008656</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochat C., Bernard-Marissal N., Kallstig E., Pradervand S., Perrin F.E., Aebischer P., Raoul C., Schneider B.L. Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis. Glia. 2022;70:842&#x2013;857. doi: 10.1002/glia.24140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.24140</ArticleId><ArticleId IdType="pmc">PMC9303637</ArticleId><ArticleId IdType="pubmed">34978340</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T., Je G., Pacut P., Keyhanian K., Gao J., Ghasemi M. Gene Therapy in Amyotrophic Lateral Sclerosis. Cells. 2022;11:2066. doi: 10.3390/cells11132066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11132066</ArticleId><ArticleId IdType="pmc">PMC9265980</ArticleId><ArticleId IdType="pubmed">35805149</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T., Cudkowicz M., Shaw P.J., Andersen P.M., Atassi N., Bucelli R.C., Genge A., Glass J., Ladha S., Ludolph A.L., et al. Phase 1&#x2013;2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.M., Cudkowicz M.E., Genge A., Shaw P.J., Sobue G., Bucelli R.C., Chi&#xf2; A., Van Damme P., Ludolph A.C., Glass J.D., et al. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2022;387:1099&#x2013;1110. doi: 10.1056/NEJMoa2204705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2204705</ArticleId><ArticleId IdType="pubmed">36129998</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005;433:73&#x2013;77. doi: 10.1038/nature03180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03180</ArticleId><ArticleId IdType="pubmed">15635412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz M.E., Titus S., Kearney M., Yu H., Sherman A., Schoenfeld D., Hayden D., Shui A., Brooks B., Conwit R., et al. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: A multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13:1083&#x2013;1091. doi: 10.1016/S1474-4422(14)70222-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70222-4</ArticleId><ArticleId IdType="pmc">PMC4216315</ArticleId><ArticleId IdType="pubmed">25297012</ArticleId></ArticleIdList></Reference><Reference><Citation>Abulseoud O.A., Alasmari F., Hussein A.M., Sari Y. Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation. Front. Neurosci. 2022;16:841036. doi: 10.3389/fnins.2022.841036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.841036</ArticleId><ArticleId IdType="pmc">PMC9294323</ArticleId><ArticleId IdType="pubmed">35864981</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Villegas J., Ferraiuolo L., Mead R.J., Shaw P.J., Cuadrado A., Rojo A.I. NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS. Free Radic. Biol. Med. 2021;173:125&#x2013;141. doi: 10.1016/j.freeradbiomed.2021.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.07.022</ArticleId><ArticleId IdType="pubmed">34314817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarlette A., Krampfl K., Grothe C., Neuhoff N., Dengler R., Petri S. Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2008;67:1055&#x2013;1062. doi: 10.1097/NEN.0b013e31818b4906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31818b4906</ArticleId><ArticleId IdType="pubmed">18957896</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkar N., Kousari A., Kovalik T., Li Y., Bowser R. RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1. Mol. Cell Biol. 2015;35:2385&#x2013;2399. doi: 10.1128/MCB.00087-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00087-15</ArticleId><ArticleId IdType="pmc">PMC4475920</ArticleId><ArticleId IdType="pubmed">25939382</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassina P., Cassina A., Pehar M., Castellanos R., Gandelman M., de Leon A., Robinson K.M., Mason R.P., Beckman J.S., Barbeito L., et al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: Prevention by mitochondrial-targeted antioxidants. J. Neurosci. 2008;28:4115&#x2013;4122. doi: 10.1523/JNEUROSCI.5308-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5308-07.2008</ArticleId><ArticleId IdType="pmc">PMC3844766</ArticleId><ArticleId IdType="pubmed">18417691</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W., Li X., Shi J., Guo Y., Li Z., Li C. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience. 2010;169:1621&#x2013;1629. doi: 10.1016/j.neuroscience.2010.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.06.018</ArticleId><ArticleId IdType="pubmed">20600671</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A., Rea S., Sultana M., Shaw B., Searle M.S., Layfield R. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling. Mol Cell Neurosci. 2016;76:52&#x2013;58. doi: 10.1016/j.mcn.2016.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2016.08.004</ArticleId><ArticleId IdType="pmc">PMC5062946</ArticleId><ArticleId IdType="pubmed">27554286</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D., Grubman A., Acevedo K., Yang S., Ke Y.D., Moujalled D.M., Duncan C., Caragounis A., Perera N.D., Turner B.J., et al. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway. Hum. Mol. Genet. 2017;26:1732&#x2013;1746. doi: 10.1093/hmg/ddx093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx093</ArticleId><ArticleId IdType="pubmed">28334913</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimoto T., Miyazaki K., Morimoto N., Kurata T., Satoh K., Ikeda Y., Abe K. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice. Brain Res. 2012;1446:109&#x2013;118. doi: 10.1016/j.brainres.2011.12.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.12.064</ArticleId><ArticleId IdType="pubmed">22353756</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M., Vargas M.R., Robinson K.M., Cassina P., Diaz-Amarilla P.J., Hagen T.M., Radi R., Barbeito L., Beckman J.S. Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis. J. Neurosci. 2007;27:7777&#x2013;7785. doi: 10.1523/JNEUROSCI.0823-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0823-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672870</ArticleId><ArticleId IdType="pubmed">17634371</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y.P., Che F.Y., Su Q.P., Lu Y.C., You C.P., Huang L.M., Wang S.G., Wang L., Yu J.X. Effects of mutant TDP-43 on the Nrf2/ARE pathway and protein expression of MafK and JDP2 in NSC-34 cells. Genet. Mol. Res. 2017;16 doi: 10.4238/gmr16029638.</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/gmr16029638</ArticleId><ArticleId IdType="pubmed">28510254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Lu Y., Qi F., Su Q., Wang L., You C., Che F., Yu J. Effect of the human SOD1-G93A gene on the Nrf2/ARE signaling pathway in NSC-34 cells. Mol. Med. Rep. 2014;9:2453&#x2013;2458. doi: 10.3892/mmr.2014.2087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2014.2087</ArticleId><ArticleId IdType="pubmed">24682253</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster A.D., Downing P., Figredo E., Polain N., Stott A., Layfield R., Rea S.L. ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation. Mol. Cell Neurosci. 2020;108:103539. doi: 10.1016/j.mcn.2020.103539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2020.103539</ArticleId><ArticleId IdType="pubmed">32835772</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P., Miquel E., Trostchansky A., Trias E., Ferreira A.M., Freeman B.A., Cassina P., Barbeito L., Vargas M.R., Rubbo H. Electrophilic nitro-fatty acids prevent astrocyte-mediated toxicity to motor neurons in a cell model of familial amyotrophic lateral sclerosis via nuclear factor erythroid 2-related factor activation. Free Radic. Biol. Med. 2016;95:112&#x2013;120. doi: 10.1016/j.freeradbiomed.2016.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.03.013</ArticleId><ArticleId IdType="pmc">PMC4867302</ArticleId><ArticleId IdType="pubmed">27012417</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Pehar M., Cassina P., Beckman J.S., Barbeito L. Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J. Neurochem. 2006;97:687&#x2013;696. doi: 10.1111/j.1471-4159.2006.03742.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03742.x</ArticleId><ArticleId IdType="pubmed">16524372</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Pehar M., Cassina P., Martinez-Palma L., Thompson J.A., Beckman J.S., Barbeito L. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: Consequences for motor neuron survival. J. Biol. Chem. 2005;280:25571&#x2013;25579. doi: 10.1074/jbc.M501920200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M501920200</ArticleId><ArticleId IdType="pubmed">15870071</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Johnson D.A., Sirkis D.W., Messing A., Johnson J.A. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J. Neurosci. 2008;28:13574&#x2013;13581. doi: 10.1523/JNEUROSCI.4099-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4099-08.2008</ArticleId><ArticleId IdType="pmc">PMC2866507</ArticleId><ArticleId IdType="pubmed">19074031</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori C.F., Possenti A., Brambilla L., Rossi D. Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders. Cells. 2021;10:2019. doi: 10.3390/cells10082019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082019</ArticleId><ArticleId IdType="pmc">PMC8395029</ArticleId><ArticleId IdType="pubmed">34440788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashrafizadeh M., Ahmadi Z., Mohammadinejad R., Farkhondeh T., Samarghandian S. Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury. Curr. Mol. Med. 2020;20:116&#x2013;133. doi: 10.2174/1566524019666191016150757.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524019666191016150757</ArticleId><ArticleId IdType="pubmed">31622191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohorko N., Repov&#x161; G., Popovi&#x107; M., Kovacs G.G., Bresjanac M. Curcumin Labeling of Neuronal Fibrillar Tau Inclusions in Human Brain Samples. J. Neuropathol. Exp. Neurol. 2010;69:405&#x2013;414. doi: 10.1097/NEN.0b013e3181d709eb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181d709eb</ArticleId><ArticleId IdType="pubmed">20448485</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson K., Chan J., Macklin E.A., Levine-Weinberg M., Breen C., Bakshi R., Grasso D.L., Wills A.-M., Jahandideh S., Taylor A.A., et al. Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2018;5:1522&#x2013;1533. doi: 10.1002/acn3.671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.671</ArticleId><ArticleId IdType="pmc">PMC6292193</ArticleId><ArticleId IdType="pubmed">30564619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Zhang Q., Ke Y., Hao J., Lu L., Lu N., Chen X. Serum uric acid levels in patients with amyotrophic lateral sclerosis: A meta-analysis. Sci. Rep. 2018;8:1100. doi: 10.1038/s41598-018-19609-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19609-2</ArticleId><ArticleId IdType="pmc">PMC5773600</ArticleId><ArticleId IdType="pubmed">29348425</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.R., Trias E., Beilby P.R., Lopez N.I., Labut E.M., Bradford C.S., Roberts B.R., McAllum E.J., Crouch P.J., Rhoads T.W., et al. Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD. Neurobiol. Dis. 2016;89:1&#x2013;9. doi: 10.1016/j.nbd.2016.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.01.020</ArticleId><ArticleId IdType="pmc">PMC4785045</ArticleId><ArticleId IdType="pubmed">26826269</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira F.G., Hatzipetros T., Thompson K., Moreno A.J., Kidd J.D., Tassinari V.R., Levine B., Perrin S., Gill A. CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits. IBRO Rep. 2017;2:47&#x2013;53. doi: 10.1016/j.ibror.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibror.2017.03.001</ArticleId><ArticleId IdType="pmc">PMC6084867</ArticleId><ArticleId IdType="pubmed">30135932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo M.T.H., Beckman J.S., Shaw C.A. Neuroprotective effect of CuATSM on neurotoxin-induced motor neuron loss in an ALS mouse model. Neurobiol. Dis. 2019;130:104495. doi: 10.1016/j.nbd.2019.104495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104495</ArticleId><ArticleId IdType="pubmed">31181282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum J.S., Brown M.L., Farrawell N.E., McAlary L., Ly D., Chisholm C.G., Snow J., Vine K.L., Karl T., Kreilaus F., et al. CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1G93A mice with a C57BL/6 background. Sci. Rep. 2021;11:19392. doi: 10.1038/s41598-021-98317-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98317-w</ArticleId><ArticleId IdType="pmc">PMC8481268</ArticleId><ArticleId IdType="pubmed">34588483</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez J.J., Terzieva S., Olabarria M., Lanza R.G., Verkhratsky A. Enriched environment and physical activity reverse astrogliodegeneration in the hippocampus of AD transgenic mice. Cell Death Dis. 2013;4:e678. doi: 10.1038/cddis.2013.194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.194</ArticleId><ArticleId IdType="pmc">PMC3702309</ArticleId><ArticleId IdType="pubmed">23788035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundquist A.J., Parizher J., Petzinger G.M., Jakowec M.W. Exercise induces region-specific remodeling of astrocyte morphology and reactive astrocyte gene expression patterns in male mice. J. Neurosci. Res. 2019;97:1081&#x2013;1094. doi: 10.1002/jnr.24430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24430</ArticleId><ArticleId IdType="pubmed">31175682</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin M., Pu T., Wang L., Marshall C., Wu T., Xiao M. Astroglial water channel aquaporin 4-mediated glymphatic clearance function: A determined factor for time-sensitive treatment of aerobic exercise in patients with Alzheimer&#x2019;s disease. Med. Hypotheses. 2018;119:18&#x2013;21. doi: 10.1016/j.mehy.2018.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2018.07.016</ArticleId><ArticleId IdType="pubmed">30122483</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampedro-Piquero P., De Bartolo P., Petrosini L., Zancada-Menendez C., Arias J.L., Begega A. Astrocytic plasticity as a possible mediator of the cognitive improvements after environmental enrichment in aged rats. Neurobiol. Learn Mem. 2014;114:16&#x2013;25. doi: 10.1016/j.nlm.2014.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nlm.2014.04.002</ArticleId><ArticleId IdType="pubmed">24727294</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz D.G., de Oliveira M.A., de Lima C.M., Foro C.A., Sosthenes M.C., Bento-Torres J., da Costa Vasconcelos P.F., Anthony D.C., Diniz C.W. Age, environment, object recognition and morphological diversity of GFAP-immunolabeled astrocytes. Behav. Brain Funct. 2016;12:28. doi: 10.1186/s12993-016-0111-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12993-016-0111-2</ArticleId><ArticleId IdType="pmc">PMC5056502</ArticleId><ArticleId IdType="pubmed">27719674</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>